News and Events

Sanovas: The 10 Fastest Growing Healthcare Solution Provider Companies

Continuous progress in medical technology has allowed doctors to diagnose better, intervene early and save lives. Early intervention and treatment not only save lives but ultimately lower related health care costs. Medical interventions, the ability to access the body without surgery to diagnose and treat, have flourished in the past few decades. Now, however, opportunity and necessity have combined to redefine what is possible through interventions and to make what is possible accessible, affordable, and safe for more people. 


Sanovas’ access, imaging, and measurement technologies enable physicians to safely perform advanced, multi-instrument and multi-modal diagnostic and therapeutic procedures in previously inaccessible anatomies. These procedures will make localized, interventional treatments for lung cancer and other serious diseases available to millions of people, globally – reducing the need for open surgeries and cancer treatments that create systemic toxicity and side effects. It is estimated that millions more healthcare providers across the globe will be able to offer their communities diagnostic and therapeutic interventions at a reasonable cost because of


Sanovas’ platform of micro technologies that are both affordable and portable. Sanovas, Inc. is a Life Science company that is developing the next generation of minimally invasive surgical tools and cancer treatment technologies. One spectacular example of the company’s innovation is their MicroCam™ Imaging Technology. These handheld ‘Plug-N-Play’ surgical cameras reduce the size of current cart based endoscopy systems by as much as 90% and reduce their costs of acquisition by up to 80% for hospitals and healthcare facilities around the world.


The company was incepted with a singular pursuit to innovate small diameter ‘Smart’ technologies that could deliver drugs and immune therapies to the periphery of the Lung to cure Lung Cancer. The course of their development forced Sanovas to overcome the many procedural risks and technological limitations required to navigate the small airways of the lungs. By successfully meeting those challenges the company has developed a portfolio of products and generated over 100 patents. These product lines are so small and so advanced that they have been found of use in advancing intervention in other areas of the body. Recognizing this opportunity, multiple subsidiary companies have been created by the company to address the unmet clinical needs in these other surgical sectors.


Sanovas Awarded Global Top 50 Start-up Company

We are excited to announce that Sanovas, Inc. was recognized as one of the Top 50 Start-Up Companies in the World at the Silicon Valley TiE50 2015 Award ceremony. TiE's carefully chosen panel of segment experts with direct domain experience screened 2,716 companies from around the world. Scoring was done on each company's IP, business model, and team.

This select list was further subjected to a higher level of diligence and screening by the expert panel of judges who are Serial Entrepreneurs, Venture Capitalists, Angel Investors, CEOs, and well-rounded Technology Experts. Upon final submission, the scores were locked-in and validated. The short-listed companies were announced as "2015 TiE50 Top Start-ups".

The final 50 chosen as "the very best of the best" - "2015 TiE50 Winners" were announced at TiEcon 2015 on May 15, 2015. Sanovas was awarded in the presence of a live audience of thousands of attendees in the main conference hall immediately following the afternoon keynote.

See the winners here

TiE50 Top Startups and Winners enjoy a distinct visibility at the conference. TiEcon 2015 presents them a great opportunity to connect with TiE Charter members from all over the world, explore business partnering and to network with leading venture capitalists, angel investors, incubators, technology hubs, serial entrepreneurs, elite charter membership, industry experts, and top-tier technology press.

Sanovas Inc. is an emerging technology company. These products are investigational medical devices that have not been approved or cleared for use in the United States.